41^th Global Psychiatry and Mental Health Conference May 23-24, 2024 Zurich, Switzerland

1. Expert Level (Scientific Service Achievement Award)
2. Professional Level (The Research Contribution Award)
3. Scholar Level (The Upcoming Researcher Award)
4. Women Scientist (The Women of Science Award)
5. Outstanding speaker
6. Best Keynote Speaker
7. Best Poster Presentation
8. Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation
9. Young Researchers Forum - Young Scientist Awards

Track 1:   Child and Adolescent Psychiatry

Track 2:   Cognitive Behavioral Therapy

Track 3:   Drug abuse and Addiction

Track 4:   Mental Health Nursing

Track 5:   Mental Health and Covid-19

Track 6:   Neuropsychology and Neurodegenerative Disorders

Track 7:   Obsessive Compulsive Disorder

Track 8:   Psychosomatic medicine

Track 9:   Psychosomatic Disorders

Track 10: Psychopharmacology

Track 11: Personality Disorders

Track 12: Sleep Disorders

Track 13: Behavioural Health Treatment and Services

Track 14: Neurodevelopmental Disorders

Track 15: Behavioural Addiction & Neuropsychology

Track 16: Psychotherapy & Psychology

Track 17: Psychoanalytic Theories & Evolutionary Psychology

Track 18: Mental Health & Psychiatry

Track 19: Adult and Geriatric Psychiatry

Track 20: Mental Disorders and Rehabilitation

Track 21: Psychopharmacology & Pharmacotherapy

Track 22: Psychoanalytic Theories

Track 23: Stress and Anxiety

Track 24: Telepsychiatry

1. American Psychiatric Association (APA) - Website
2. American Psychological Association (APA) - Website
3. World Psychiatric Association (WPA) - Website
4. National Alliance on Mental Illness (NAMI) - Website
5. American Academy of Child and Adolescent Psychiatry (AACAP) - Website
6. American Counseling Association (ACA) - Website
7. National Institute of Mental Health (NIMH) - Website
8. International Society of Psychiatric-Mental Health Nurses (ISPN) - Website
9. Royal College of Psychiatrists - Website
10. Canadian Psychiatric Association (CPA) - Website

Related Universities: 

1. Harvard University 
2. Stanford University
3. University of California, San Francisco (UCSF)
4. Johns Hopkins University
5. Yale University
6. Columbia University
7. University of Pennsylvania 
8. University of Oxford 
9. University College London (UCL) 
10. University of Cambridge 

Attending the 41st Global Psychiatry and Mental Health Conference can offer numerous benefits for professionals, researchers, and individuals interested in the field. Here are several reasons why attending such a conference can be valuable:

1. Knowledge Expansion: Conferences provide access to the latest research, developments, and advancements in psychiatry and mental health. Attendees can learn about cutting-edge treatments, innovative therapies, and emerging trends in the field.

2. Networking Opportunities: Conferences bring together professionals from diverse backgrounds, including clinicians, researchers, educators, and policymakers. These events offer ample opportunities for networking, collaboration, and building professional relationships.

3. Exposure to Different Perspectives: Conferences feature presentations, workshops, and panel discussions led by experts from around the world. Attendees gain exposure to diverse perspectives, approaches, and methodologies, enriching their understanding of mental health issues and treatment options.

4. Professional Development: Conferences often offer workshops, seminars, and continuing education sessions that contribute to professional development and skill enhancement. Attendees can acquire new knowledge, techniques, and strategies to improve their practice or research endeavors.

5. Presentation Opportunities: Conferences provide a platform for researchers, practitioners, and students to present their work, share findings, and receive feedback from peers and experts in the field. Presenting at a conference can enhance visibility, credibility, and recognition within the mental health community.

6. Stay Updated on Industry Trends: Attending conferences allows professionals to stay informed about industry trends, policy changes, and regulatory updates affecting the field of psychiatry and mental health. This knowledge is essential for staying current and adapting to evolving practices and standards of care.

7. Inspiration and Motivation: Conferences often feature keynote speakers and sessions that inspire and motivate attendees. Hearing from influential leaders and experts can rekindle passion, spark creativity, and reinforce the importance of their work in improving mental health outcomes.

8. Access to Resources: Conferences typically include exhibitions or resource centers where attendees can explore products, services, and resources related to psychiatry and mental health. This can include books, journals, software, and other tools that support clinical practice, research, or education.

Psychiatrists and Mental Health Professionals: Clinicians, psychiatrists, psychologists, counselors, therapists, and social workers seeking to enhance their understanding of new research findings, treatment approaches, and best practices.

Researchers and Academics: Academicians, researchers, and scholars interested in presenting their cutting-edge research, sharing insights, and engaging in academic discussions to contribute to the field's knowledge base.

Medical Practitioners: General practitioners, medical doctors, and specialists interested in expanding their knowledge of mental health issues and incorporating mental health care into their practice.

Nursing and Allied Health Professionals: Nurses, nurse practitioners, occupational therapists, and other allied health professionals looking to deepen their understanding of mental health care and its integration into their work.

Policy Makers and Advocates: Government officials, policymakers, and advocates for mental health awareness, policy development, and improved access to mental health services.

Educators and Trainers: Professionals involved in training and education, including educators, trainers, and curriculum developers focused on mental health education and awareness.

Students and Early Career Professionals: Aspiring professionals, graduate students, and early career individuals seeking to learn, network, and gain exposure to the latest advancements in psychiatry and mental health.

Industry Representatives: Representatives from pharmaceutical companies, technology providers, and mental health organizations interested in showcasing innovative products, services, and technologies related to mental health care.

Community and Non-profit Organizations: Representatives from community-based organizations, non-profits, and NGOs working to promote mental health awareness, support, and resources.

International Delegates: Professionals and researchers from around the world interested in sharing global perspectives, experiences, and solutions related to mental health challenges.

The Al Baraha Global Psychiatry and Psychology market plays a significant role in contributing $34.5 billion to the industry, with key countries such as the US (74%), Europe (64%), Japan (8.3%), and the UAE (7.8%).

Abuse and Addiction Treatment Market Analysis

The market size for substance abuse treatment was valued at $10 billion in 2020 and is projected to reach $18.7 billion by 2028, exhibiting a CAGR of 8% from 2021 to 2028.

Pediatric Medicines Market Analysis

The global pediatric market is anticipated to grow from $92.6 billion in 2019 to approximately $116.6 billion by 2024, showcasing a compound annual growth rate (CAGR) of 4.7% during the period of 2019 to 2024.

Anti-Psychotic Drugs Market Analysis

The worldwide market for antipsychotic drugs was valued at $12,417.60 million in 2020 and is predicted to expand to $26,041.00 million by 2030, with a CAGR of 8.0% from 2021 to 2030. These drugs are primarily used to treat conditions such as schizophrenia and bipolar disorder.

CNS Biomarker Market Analysis

The central nervous system biomarkers market is estimated to experience a CAGR of 7.5% during the forecast period. It achieved revenue of around $4,652 million in 2020 and is projected to reach approximately $7,160 million by 2026. The COVID-19 pandemic had a notable impact on this market.

Funding Allocation for Psychiatry Research

Key research institutions receive significant funding for psychiatry research, including:

• NIHR (National Institute for Health Research) - $1.05 billion
• HBP (Human Brain Project) - $1.3 billion
• BRI (Brain Research Initiative) - $0.1 billion

Projected Cost of Anxiety and Depression Treatment:

The estimated total cost of treating anxiety and depression disorders across 36 countries worldwide is projected to be $147 billion by 2030.

Mental Health Funding and Initiatives in Australia:

In Australia, mental health and behavioral disorders are addressed through the National Survey of Mental Health and Wellbeing, initiated in 1990. Various government bodies have collaborated through the National Mental Health Strategy to develop programs and services aimed at meeting the mental health needs of Australians.

Financial Breakdown in Australia:

For mental health-related services, approximately $9.0 billion, or $373 per person, was spent in 2015-16. Of this amount, 59.8% ($5.4 billion) was funded by state and territory governments, 35% ($3.1 billion) by the Australian government, and 5.2% ($466 million) by private health insurance funds.

Funding for Research Initiatives

Brain Research Initiative

The Brain Research through Advancing Innovative Technology project was initiated by the Obama Administration to comprehensively map the human brain's functions. In FY 2014, a $100 million fund was allocated to the National Institutes of Health for this purpose.

National Institute for Health Research (NIHR)

During 2012/13, NIHR had a total research cost of £958.9 million, with £208.9 million directed towards research programs and £618.9 million invested in infrastructure. Faculty members, including senior investigators and fellows, received £100 million.

Human Brain Project (HBP)

The Human Brain Project, a long-term endeavor, is estimated to cost 1.19 billion euros over a ten-year period (2013-2023).

PROJECTIONS: Growth in the Next 5 to 10 Years

Psychiatrists

Demand for psychiatrists is anticipated to rise from approximately 18,180 to 21,440 by 2025.

The Human Brain Project

The primary goal of the HBP is to collaboratively develop an initial "scaffold" model and simulation of the human brain by 2023.

Healthy People 2020

This initiative outlines national health objectives aimed at identifying preventable health threats and establishing goals to reduce psychiatric problems.

WPA Member Societies and Sections

Plans include a significant increase in the number of psychiatrists in the near future, along with improvements in the distribution of the journal. The journal, available in English and electronic versions, is expanding to Chinese, Spanish, Portuguese, and Japanese editions.

Global Burden of Disease: Collaborative Project (2005 to 2030)

The World Health Organization (WHO) initiated global public health projects, including the Public Health and Global Initiative on Psychiatry. The objective is to raise awareness about the prevalence, extent, and costs of disorders, advocating for comprehensive psychiatric and psychological care across all healthcare levels.

Human Connectome

The NIH Human Connectome Project is an ambitious effort to map the neural pathways underlying human brain function, aiming to acquire and share data about structural and functional brain connectivity.

ROOTS: Investigating Adolescent Psychopathology Origins

This project delves into various aspects of teenage mental health during the challenging adolescent period, not limited to depression. It aims to understand how specific genetic, physiological, psychological, and social factors contribute to psychopathology risk during adolescence. Participants are enrolled at age 14 and followed until they reach 17-18 years of age.

Definition of the Psychiatrists Market

The psychiatrists market encompasses the provision of psychiatrists' services and related products by entities such as organizations, sole traders, and partnerships. These entities are engaged in diagnosing, treating, and preventing mental, emotional, and behavioral disorders. The industry includes licensed practitioners holding degrees of M.D. (Doctor of Medicine) or D.O. (Doctor of Osteopathic Medicine) who offer palliative care, address psychosomatic disorders, mental disorders, and more. Psychiatrists practice in private or group settings, either in their own offices (e.g., centers, clinics) or within the facilities of other entities such as hospitals or health maintenance organization (HMO) medical centers.

Global Mental Health Market Trends

The global mental health market was valued at $383.31 million in 2020 and is forecasted to reach $537.97 million by 2030, with a projected Compound Annual Growth Rate (CAGR) of 3.5% from 2021 to 2030.

Trends Influencing the Psychiatrists Market

Key trends shaping the psychiatrists market include

Advances in Psychiatric Genetics

Ongoing studies in psychiatric genetics are revealing complex links to mental health disorders. Genetic research enhances understanding of the causes behind mental health conditions, leading to improved treatment methods. Recent discoveries related to anorexia highlighted the role of genetics in metabolic factors contributing to the disorder, ultimately providing insights into major mental health conditions.

Adoption of Mobile and Connected Technologies for Psychiatric Diagnosis

Psychiatric care providers are integrating mobile and connected technologies to aid in diagnosing and treating mental illnesses. This includes the evolution of electronic medical records, real-time patient health monitoring through data collection, and utilization of e-tools for behavioral and physiological tracking. These technologies offer novel avenues for psychiatric diagnosis and treatment.

Opportunities and Recommendations in the Psychiatrists Market

Opportunities- The most promising opportunities in the global psychiatrists market are expected in the segment of psychiatric services for mood disorders (anxiety and depression), projected to generate $19.2 billion. The USA is likely to see the most substantial growth, with a gain of $19.1 billion.

Recommendations- To leverage these opportunities, The Business Research Company suggests that psychiatry service providers should consider:

Offering cognitive-behavioral therapy interventions.

Collaborating across sectors to provide value-based healthcare.

Focusing on treatment services, preventive measures, and promotional activities delivered through primary care centers.

Initiating educational and awareness programs about mental health issues.

Psychiatrists Market Segmentation:

The psychiatrists market is divided by the type of mental disorder, patient type, and geography.

By Mental Disorder Type:

Segments include

a) Alcohol Abuse Mental And Behavioral Disorders

b) Psychoactive Substance Use Mental And Behavioral Disorders

c) Schizophrenia, Schizotypal And Delusional Disorders

d) Mood (Anxiety And Depression) Disorders

e) Other Mental And Behavioral Disorders

The psychoactive substance use mental and behavioral disorders segment demonstrated the highest historic growth rate of nearly 13.5%.

By Patient Type- Segments comprise:

a) Inpatient

b) Outpatient

The psychoactive substance use mental and behavioral disorders outpatient segment exhibited the highest historic growth rate of nearly 15.0%.

By Geography:

Geographic segments include- North America, USA, Western Europe, UK, Germany, France, Spain, Italy, Asia, China, Japan, India, Australia, Russia, Brazil, Middle East, Africa.

North America leads the psychiatrists market, accounting for 47.9% of the global share. Future growth is expected to be strongest in the Middle East and Africa regions.